- Home
- TANH vs VRAX Comparison
TANH vs VRAX Comparison
Compare TANH & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TANH
- VRAX
- Stock Information
- Founded
- TANH 2001
- VRAX 2013
- Country
- TANH China
- VRAX United Kingdom
- Employees
- TANH N/A
- VRAX N/A
- Industry
- TANH
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TANH
- VRAX Health Care
- Exchange
- TANH Nasdaq
- VRAX Nasdaq
- Market Cap
- TANH 2.6M
- VRAX 2.8M
- IPO Year
- TANH 2015
- VRAX 2022
- Fundamental
- Price
- TANH $1.59
- VRAX $0.59
- Analyst Decision
- TANH
- VRAX Strong Buy
- Analyst Count
- TANH 0
- VRAX 1
- Target Price
- TANH N/A
- VRAX $3.00
- AVG Volume (30 Days)
- TANH 189.4K
- VRAX 180.0K
- Earning Date
- TANH 05-15-2025
- VRAX 01-01-0001
- Dividend Yield
- TANH N/A
- VRAX N/A
- EPS Growth
- TANH N/A
- VRAX N/A
- EPS
- TANH N/A
- VRAX N/A
- Revenue
- TANH $42,940,136.00
- VRAX $6,331.00
- Revenue This Year
- TANH N/A
- VRAX $217,274.83
- Revenue Next Year
- TANH N/A
- VRAX N/A
- P/E Ratio
- TANH N/A
- VRAX N/A
- Revenue Growth
- TANH N/A
- VRAX N/A
- 52 Week Low
- TANH $1.45
- VRAX $0.52
- 52 Week High
- TANH $10.77
- VRAX $3.20
- Technical
- Relative Strength Index (RSI)
- TANH 41.11
- VRAX 39.31
- Support Level
- TANH $1.61
- VRAX $0.60
- Resistance Level
- TANH $1.77
- VRAX $0.67
- Average True Range (ATR)
- TANH 0.14
- VRAX 0.04
- MACD
- TANH -0.01
- VRAX -0.00
- Stochastic Oscillator
- TANH 13.59
- VRAX 5.08
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).